Mr Bryan Elrod, CRNA | |
1700 Mount Vernon Ave, Bakersfield, CA 93306-4018 | |
(661) 326-2000 | |
Not Available |
Full Name | Mr Bryan Elrod |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 4 Years |
Location | 1700 Mount Vernon Ave, Bakersfield, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003436551 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 95001299 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kern Medical Center | Bakersfield, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regional Anesthesia Associates Inc | 7810275096 | 42 |
News Archive
CarThera, a French company based at the Brain and Spine Institute, that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the publication in Science Translational Medicine of a scientific paper on initial successes in disrupting the blood-brain barrier (BBB) with the use of ultrasound.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA.
› Verified 4 days ago
Entity Name | Community Foundation Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811258510 PECOS PAC ID: 0345406294 Enrollment ID: O20120723000387 |
News Archive
CarThera, a French company based at the Brain and Spine Institute, that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the publication in Science Translational Medicine of a scientific paper on initial successes in disrupting the blood-brain barrier (BBB) with the use of ultrasound.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA.
› Verified 4 days ago
Entity Name | Regional Anesthesia Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811442874 PECOS PAC ID: 7810275096 Enrollment ID: O20161021001369 |
News Archive
CarThera, a French company based at the Brain and Spine Institute, that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the publication in Science Translational Medicine of a scientific paper on initial successes in disrupting the blood-brain barrier (BBB) with the use of ultrasound.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA.
› Verified 4 days ago
Entity Name | Garrett S Hilt Certified Registered Nursing Anesthesia Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497278949 PECOS PAC ID: 8628338381 Enrollment ID: O20180131000983 |
News Archive
CarThera, a French company based at the Brain and Spine Institute, that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the publication in Science Translational Medicine of a scientific paper on initial successes in disrupting the blood-brain barrier (BBB) with the use of ultrasound.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA.
› Verified 4 days ago
Entity Name | Advanced Anesthesia Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720543762 PECOS PAC ID: 4880936145 Enrollment ID: O20190507001500 |
News Archive
CarThera, a French company based at the Brain and Spine Institute, that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the publication in Science Translational Medicine of a scientific paper on initial successes in disrupting the blood-brain barrier (BBB) with the use of ultrasound.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA.
› Verified 4 days ago
Entity Name | Valley Regional Anesthesia Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578272415 PECOS PAC ID: 3870964323 Enrollment ID: O20230120001928 |
News Archive
CarThera, a French company based at the Brain and Spine Institute, that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the publication in Science Translational Medicine of a scientific paper on initial successes in disrupting the blood-brain barrier (BBB) with the use of ultrasound.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Bryan Elrod, CRNA 5704 Thorner St, Bakersfield, CA 93306-7343 Ph: (661) 565-6686 | Mr Bryan Elrod, CRNA 1700 Mount Vernon Ave, Bakersfield, CA 93306-4018 Ph: (661) 326-2000 |
News Archive
CarThera, a French company based at the Brain and Spine Institute, that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the publication in Science Translational Medicine of a scientific paper on initial successes in disrupting the blood-brain barrier (BBB) with the use of ultrasound.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective than varenicline alone at achieving tobacco abstinence at 6 months, according to a study in the July 9 issue of JAMA.
› Verified 4 days ago
Alan Kim, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11704 Nantwick Ct, Bakersfield, CA 93311 Phone: 714-269-0275 | |
Mr. Randy C. Willeby, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2128 Fax: 661-326-2129 | |
Lucille Petersen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 | |
Jane Fickes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 | |
Sunita Bendale, MSN, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 | |
Muhammad Murtaza Rizvi, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 714-270-6337 |